COX-2 inhibitor research
Saved in:
Corporate Author: | |
---|---|
Other Authors: | |
Format: | Electronic eBook |
Language: | English |
Published: |
New York :
Nova Science Publishers,
c2006.
|
Subjects: | |
Online Access: | An electronic book accessible through the World Wide Web; click to view |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Cyclooxygenase-2 inhibitor and gastric cancer / Yumin Li, Raaj K. Praseedom, and Andrew Butler et al.
- Prevention and chemoprevention of gastric cancer : dietary habits, Helicobacter pylori and COX-2 inhibitors / Gerardo Nardone and Alba Rocco
- Cyclooxygenases in cancer / Daniela Fodera ... et al.
- Nephrotoxicity of nonsteroidal anti-inflammatory drugs : focus on selective cyclooxygenase-2 (COX-2) inhibitors / Steven G. Coca and Mark A. Perazella
- Are COX-2 inhibitors active on intracellular oxidative processes? A study on in vitro and cellular models / Ange Mouithys-Mickalad et al.
- Theoretical mechanism studies on dual inhibition of human cyclooxygenase-2 and 5-lipoxygenase by diaryl-pyrrolizine derivatives / R. Pouplana, C. Perez, and J. Ruiz
- NSAIDs in animal models of Alzheimer's disease / N.G. Giovannini, C. Scali, and A. Bellucci
- Relevance of COX-2 inhibitors in Alzheimer's disease / Amita Quadros, Laila Abdullah, and Nikunj Patel et al.
- COX.1-COX.2 simultaneous inhibitory mechanism in gastric injury and COX.2-COX.3 in small intestine injury / Laudanno Oscar
- Effects of COX-2 inhibitors on brain diseases / Takako Takemiya
- Cyclooxygenase-2 overexpression and the chemopreventive and therapeutic uses of cyclooxygenase inhibitors in lung cancer / Zhongxing Liao et al.
- Safety monitoring of celecoxib and rofecoxib in the New Zealand intensive medicines monitoring programme / David Coutler et al.